Citation: B. Suchy et al., ABSENCE OF RAS AND P53 MUTATIONS IN THYROID CARCINOMAS OF CHILDREN AFTER CHERNOBYL IN CONTRAST TO ADULT THYROID-TUMORS, British Journal of Cancer, 77(6), 1998, pp. 952-955
Authors:
BOCK M
WALDMANN V
JACKEL A
DEICHMANN M
NAHER H
Citation: M. Bock et al., CHEMOTHERAPY OF METASTATIC MALIGNANT-MELANOMA - OUTCOME OF DIFFERENT TREATMENT PROTOCOLS, British Journal of Cancer, 77, 1998, pp. 1730-1730
Authors:
SCHEIBENBOGEN C
LEE KH
STEVANOVIC S
WITZENS M
WILLHAUCK M
WALDMANN V
NAEHER H
RAMMENSEE HG
KEILHOLZ U
Citation: C. Scheibenbogen et al., ANALYSIS OF THE T-CELL RESPONSE TO TUMOR AND VIRAL PEPTIDE ANTIGENS BY AN IFN-GAMMA-ELISPOT ASSAY, International journal of cancer, 71(6), 1997, pp. 932-936
Citation: V. Waldmann et Hm. Rabes, ABSENCE OF G(S)ALPHA GENE-MUTATIONS IN CHILDHOOD THYROID-TUMORS AFTERCHERNOBYL IN CONTRAST TO SPORADIC ADULT THYROID NEOPLASIA, Cancer research, 57(12), 1997, pp. 2358-2361
Citation: V. Waldmann et Hm. Rabes, WHATS NEW IN RAS GENES - PHYSIOLOGICAL-ROLE OF RAS GENES IN SIGNAL-TRANSDUCTION AND SIGNIFICANCE OF RAS GENE ACTIVATION IN TUMORIGENESIS, Pathology research and practice, 192(9), 1996, pp. 883-891
Citation: V. Waldmann et Hm. Rabes, PROLIFERATIVE HETEROGENEITY OF HUMAN RENAL-CELL CARCINOMAS AND PREVALENCE OF RAS GENE POINT MUTATIONS, Journal of cancer research and clinical oncology, 122(4), 1996, pp. 207-213
Citation: V. Waldmann et al., CELL-PROLIFERATION AND PREVALENCE OF RAS GENE-MUTATIONS IN 7,12-DIMETHYLBENZ(A)ANTHRACENE (DMBA)-INDUCED RAT MAMMARY-TUMORS, Research in experimental medicine, 193(3), 1993, pp. 143-151